TELAML1 Quantitative Test Cost AED:1200.0 – Symptoms, Diagnosis, and More
Are you concerned about T-cell acute lymphoblastic leukemia (T-ALL)? DNA Labs UAE offers the TELAML1 Quantitative Test at a cost of AED 1200.0. This test is a crucial tool for the diagnosis and management of T-ALL patients.
Test Name: TELAML1 Quantitative Test
- Components: EDTA Vacutainer (2ml)
- Price: 1200.0 AED
- Sample Condition: Bone marrow / Peripheral blood (Transport immediately)
- Report Delivery: 3-4 days
- Method: Real Time PCR
- Test Type: Genetics
- Doctor: General Physician
- Test Department:
Pre Test Information
TEL/AML1 Quantitative Test requires a doctor’s prescription. However, please note that the prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
TEL/AML1 is a fusion gene associated with T-cell acute lymphoblastic leukemia (T-ALL). It is formed due to a chromosomal translocation between the TEL (ETV6) gene on chromosome 12 and the AML1 (RUNX1) gene on chromosome 21. The TEL/AML1 Quantitative Test measures the levels of the fusion transcript in patient samples using techniques such as real-time polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH).
Quantification of TEL/AML1 transcripts is crucial for several reasons. Firstly, it aids in the diagnosis of T-ALL as the presence of the fusion gene is a characteristic feature of this subtype. Secondly, it helps monitor the response to treatment, as a decrease in the levels of the fusion transcript indicates a favorable response. Lastly, it can detect minimal residual disease (MRD), which refers to a small number of leukemia cells that may remain in the body after treatment and can potentially lead to relapse.
By analyzing TEL/AML1 quantitatively, valuable information for the management of T-ALL patients can be obtained. This includes early detection of relapse and adjustment of treatment strategies.
Don’t wait! Get your TELAML1 Quantitative Test done at DNA Labs UAE today.
Test Name | TELAML1 Quantitative Test |
---|---|
Components | EDTA Vacutainer (2ml) |
Price | 1200.0 AED |
Sample Condition | Bone marrow \/ Peripheral blood (Transport immediately) |
Report Delivery | 3-4 days |
Method | Real Time PCR |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | TEL/AML1 Quantitative can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details |
TEL/AML1 is a fusion gene that is associated with a specific subtype of acute lymphoblastic leukemia (ALL) called T-cell acute lymphoblastic leukemia (T-ALL). It is formed as a result of a chromosomal translocation between the TEL (ETV6) gene on chromosome 12 and the AML1 (RUNX1) gene on chromosome 21. Quantitative analysis of the TEL/AML1 fusion gene involves measuring the levels of the fusion transcript in patient samples. This can be done using techniques such as real-time polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH). The quantification of TEL/AML1 transcripts is important for several reasons. Firstly, it helps in the diagnosis of T-ALL, as the presence of the fusion gene is a characteristic feature of this subtype. Secondly, it can be used to monitor the response to treatment, as a decrease in the levels of the fusion transcript indicates a favorable response. Lastly, it can be used to detect minimal residual disease (MRD), which refers to the small number of leukemia cells that may remain in the body after treatment and can potentially lead to relapse. Quantitative analysis of TEL/AML1 can provide valuable information for the management of T-ALL patients, allowing for early detection of relapse and adjustment of treatment strategies. |